Akin advises clients in the medical device, diagnostics, pharma, biotech, AI, and food and dietary supplement sectors. The firm combines experience in FDA regulatory matters with CMS coverage and reimbursement issues, and has a focus on digital health and AI in healthcare. Based in Washington, DC, Nathan Brown leads the FDA practice while Kelly Cleary advises on healthcare regulatory, policy, and enforcement matters.
Legal 500 Editorial commentary
Accolades
Client satisfaction: Lawyer & team quality
Client satisfaction: Sector knowledge
Client satisfaction: NPS ®
Testimonials
Collated independently by Legal 500 research team.
‘Nate Brown is a creative legal thought partner; sophisticated business advisor; is deeply plugged into regulatory and legislative initiatives and developments; broad industry perspective; incredibly strategic with regulatory and legal solutions.’
Key clients
- AdvaMed
- Precision Diagnostics, LLC
- Simtra BioPharma Solutions
- Apollo Laboratories Services, LLC
- Siemens Corporation
- Johnson & Johnson
- LabCorp (Laboratory Corporation of America)
- Solvd
- Opella
- United States Pharmacopeial Convention
- Resmed Corp.
Work highlights
Acting as outside regulatory counsel to AdvaMed.
Represented Apollo Laboratories Services, LLC, and all other individual and corporate defendants in a FCA qui tam action.
Represented Precision Diagnostics, LLC (Precision) with respect to several FCA private whistleblower lawsuits filed against Precision, a clinical laboratory.
Lawyers
Leading partners
The strongest partners in their field, leading on market-leading deals and endorsed by peers and clients alike.
Next Generation Partners
Junior partners with significant recognition from clients and peers in the market and key roles on multiple matters.
Practice head
Nate Brown
Other key lawyers
Kelly Cleary